August 17, 2018
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
“Transcranial magnetic stimulation has shown its potential to help patients suffering from depression and headaches,” said Carlos Peña, Ph.D., M.S., director of the Division of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health. “With today’s marketing authorization, patients with OCD who have not responded to traditional treatments now have another option.”
August 04, 2016
Comparison between neurostimulation techniques repetitive transcranial magnetic stimulation vs electroconvulsive therapy for the treatment of resistant depression: patient preference and cost-effectiveness
Major depressive disorder (MDD) is a common disorder, widely distributed in the population, and is often associated with severe symptoms and functional impairment. It has been estimated that 30% of MDD patients do not benefit adequately from therapeutic interventions, including pharmacotherapy and psychotherapy. Treatment-resistant depression (TRD) is generally defined as a failure to achieve remission, despite therapeutic interventions.
June 26, 2015
Transcranial magnetic stimulation for the treatment of major depression
There is a signal that TMS may bene t certain sub- groups of patients who previously would be referred for ECT. The durability of TMS’ antidepressant bene t and safety and tolerability pro le make it an attractive treatment option for selected patients.
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder
TMS therapy uses a computerized, electromechanical medical device to produce and deliver non-invasive,magnetic stimulation using brief duration,rapidly alternating,or pulsed,magnetic ﬁelds to induce electrical currents directed at spatially discrete regions of the cerebralcortex. This method of cortical stimulation by application of brief magnetic pulses to the head is known as transcranial magnetic stimulation or TMS.
February 05, 2015
Efficacy and Safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial
Major depressive disorder (MDD) is a prevalent and disabling condition, and many patients do not respond to available treatments. Deep transcranial magnetic stimulation (dTMS) is a new technology allowing non-surgical stimulation of relatively deep brain areas. This is the first double-blind randomized controlled multicenter study evaluating the efficacy and safety of dTMS in MDD.
Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression
The study suggests that deep TMS “DTMS,” when used as an augmenting strategy for antidepressants in severe TRD, is efficacious, safe and relatively well tolerated.